Axon Enterprise, Inc. (AXON) is a public safety technology company, not an exchange-traded fund. It develops TASER conducted-energy weapons, body cameras, cloud-based digital evidence management, and counter-drone systems.
The $560 central target reflects the average of roughly 21 current analyst price targets, which range from about $380 to $700. The Street view remains bullish overall, with a consensus rating near "Buy," but the range is unusually wide. Cautious names sit at the low end—UBS reiterated a Hold with a $380 target—while the most optimistic, such as Citizens JMP near $700, expect the counter-drone and software businesses to reaccelerate.
The targets were materially reset after third-quarter results. On November 6, several firms cut targets while keeping Buy or Outperform ratings: JPMorgan to $610 from $755, RBC Capital to $615 from $735, TD Cowen to $650 from $800, Needham to $500 from $750, Raymond James to $475 from $675, Barclays to $507 from $688, and Piper Sandler to $540 from $561. Craig-Hallum downgraded the stock to Hold. Analysts generally cite software durability on one side and hardware and margin volatility on the other.
The stock closed near $313 after an 18% single-day decline following its November 5 earnings report, leaving shares down roughly 45% for the year. Reaching $560 would require about 79% upside, a very large move that implies both restored earnings growth and a higher valuation multiple.
The path depends on fundamentals. Third-quarter revenue rose 28% year over year to about $909 million, but missed estimates, and earnings per share (EPS) also came in light. Management lowered full-year revenue guidance to roughly $3.61–$3.63 billion and cut its FCF outlook to $350–$400 million. Still, software and services revenue grew 43%, ARR rose 40% to $1.8 billion, and contracted bookings reached $15.8 billion, suggesting recurring demand remains intact.
On valuation, AXON trades at a premium—roughly 35 times next-twelve-month earnings at the recent price, well below its five-year average near 77 times—so multiple compression has already occurred.
The earnings-driven selloff broke the stock below its prior trading zone near $380–$420, leaving a gap from roughly $383 down to the low $300s. The $300 area now stands as a psychological support level, while the gap zone and prior range form overhead resistance that would need to be reclaimed before a sustained move toward $560 becomes technically credible.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual assumptions vary. Key items to watch include fourth-quarter results and the company's ~$450 million FCF goal, whether delayed federal counter-drone revenue is realized, the timing of Skydio deal closings through early 2027, analyst revisions, and broader sentiment toward high-multiple growth stocks.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to uncover opportunities, keep an eye on existing positions, and spot changing trends more efficiently than manual screening. Consider pairing these AI signals with your own research on AXON to stay ahead of evolving market conditions.
The $560 target is the average of current analyst price targets, not a guarantee, and it implies roughly 79% upside from the recent $313 price—a very large move. Support comes from durable software and ARR growth and a deep bookings backlog, while the principal obstacles are delayed federal counter-drone revenue, weak free cash flow, and a premium valuation. Wide analyst disagreement—targets ranging from $380 to $700—underscores real uncertainty. Investors should watch cash flow, guidance, and whether deferred deals ultimately close before drawing conclusions about a move toward $560.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | +2.71% | ||
| TECH - AXON | 61% Loosely correlated | +0.05% | ||
| VCYT - AXON | 58% Loosely correlated | -1.22% | ||
| BEAM - AXON | 57% Loosely correlated | -4.99% | ||
| SEER - AXON | 56% Loosely correlated | -1.26% | ||
| ADPT - AXON | 56% Loosely correlated | -1.49% | ||
More | ||||